Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 17, 2020 11:31 PM 4 min read

Structural Heart Devices Market 2020: Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2027

by COMSERVE
Follow

New York, United States, Wed, 18 Nov 2020 04:31:58 / Comserve Inc. / -- The market for structural heart devices is estimated to record a CAGR of around 9.5% over the forecast period, i.e., 2019-2027

Research Nester released a report titled "Structural Heart Devices Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global structural heart devices market in terms of market segmentation by product, by procedure, by indication and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.

The market for structural heart devices is estimated to record a CAGR of around 9.5% over the forecast period, i.e., 2019-2027. The market is segmented by product, by procedure, by indication and by region. Based on the product segment, the market is divided into heart valves, occluders, annuloplasty rings, accessories and others, out of which, the heart valves segment is anticipated to hold the largest share in the structural heart devices market. Further, the procedure segment is bifurcated into repair and replacement, out of which, the replacement procedure segment is predicted to observe the highest growth on account of rising demand for trans-catheter replacement procedures.

The Final Report will cover the impact analysis of COVID-19 on this industry: https://www.researchnester.com/sample-request-2121

The market in North America is estimated to hold the leading share in structural heart devices market on account of increasing cases of structural heart disease related surgeries in the region. Moreover, the advancements in medical technology and devices and the growing expenditure on healthcare by people in the region, mainly in the United States, are factors estimated to further contribute towards the market growth. On the other hand, the market in Asia Pacific region is predicted to grow at the highest rate over the forecast period on account of the large population and unhealthy lifestyle in Asian countries including China and India.

Rising Number of Structural Heart Diseases to Boost the Market Growth

The Centers for Disease Control and Prevention estimated through a study in Atlanta that around one in every 770 babies born in the Unites States every year were born with an atrial septal defect.

The growing population along with rising genetic defects that affect the heart, such as congenital heart defects, are some factors estimated to increase the demand for structural heart devices in the coming years. This is anticipated to positively affect the market growth over the forecast period. However, the treatment for structural heart diseases requires surgical procedures which are highly costly. This is estimated to hinder the market growth.

Request For Full Report @ https://www.researchnester.com/sample-request-2121

This report also provides the existing competitive scenario of some of the key players of the global structural heart devices market which includes company profiling of Abbott (NYSE:ABT), Boston Scientific Corporation (NYSE:BSX), Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT), Corvia Medical, Inc., Comed B.V., JenaValve Technology, Inc., LivaNova PLC (NASDAQ:LIVN), XELTIS and CryoLife, Inc. (NYSE:CRY). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global structural heart devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Read More Information@ https://www.researchnester.com/reports/structural-heart-devices-market/2121

For more information, please contact:

AJ Daniel

Research Nester
Email: [email protected]
Tel: +1-6465869123

The post Structural Heart Devices Market 2020: Size, Share, Demands, Growth, Opportunities, Trends Analysis and Forecast Till 2027 appeared first on Comserveonline.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


ABT Logo
ABTAbbott Laboratories
$112.97-0.56%
Overview
BSX Logo
BSXBoston Scientific Corp
$73.21-0.86%
EW Logo
EWEdwards Lifesciences Corp
$85.19-0.11%
LIVN Logo
LIVNLivaNova PLC
$68.15-0.41%
MDT Logo
MDTMedtronic PLC
$96.69-0.02%

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

ABT Logo
ABTAbbott Laboratories
$112.97-0.56%
Overview
BSX Logo
BSXBoston Scientific Corp
$73.21-0.86%
EW Logo
EWEdwards Lifesciences Corp
$85.19-0.11%
LIVN Logo
LIVNLivaNova PLC
$68.15-0.41%
MDT Logo
MDTMedtronic PLC
$96.69-0.02%
Comments
Loading...